Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Cash from Investing Activities

Adverum Biotechnlgs Cash from Investing Activities Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Cash from Investing Activities from 2013 to 2020.
  • Adverum Biotechnlgs Cash from Investing Activities for the quarter ending June 06, 2020 was $-89m a 83.06% decrease of -74m year over year
  • Adverum Biotechnlgs Cash from Investing Activities for the last 12 months ending June 06, 2020 was $-194m a 78.91% decrease of -153m year over year
  • Adverum Biotechnlgs Annual Cash from Investing Activities for 2019 was $-68m a 202.01% decrease of -138m from 2018
  • Adverum Biotechnlgs Annual Cash from Investing Activities for 2018 was $69m a 275.97% increase of 192m from 2017
  • Adverum Biotechnlgs Annual Cash from Investing Activities for 2017 was $-122m a 131.73% decrease of -161m from 2016
Other Cash Flow Metrics:
  • Adverum Biotechnlgs Cash Flow from Operations for the quarter ending December 12, 2018 was $-13m a -2.00% increase of 0m year over year
  • Adverum Biotechnlgs Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-26m a 70.14% decrease of -18m year over year
  • Adverum Biotechnlgs Total Revenue for the quarter ending September 09, 2018 was $1m a 44.66% increase of 0m year over year
View Chart On Koyfin

Quarterly ADVM Cash from Investing Activities Data

06/2020$-89m
03/2020$-71m
12/2019$-19m
09/2019$-15m
06/2019$-37m
03/2019$3m
12/2018$8m
09/2018$21m
06/2018$15m
03/2018$25m

Annual ADVM Cash from Investing Activities Data

2019$-68m
2018$69m
2017$-122m
2016$39m
2015$-42m
2014$-1m
2013$0m
2012$0m